In addition to striving to maximize the efficiency of its research center, GC Biopharma continues to generate R&D synergy through active investments in biotechnology startups, leading corporations, and extensive partnerships with universities and research organizations worldwide. In particular, the collaboration between the MOGAM Institute for Biomedical Research and partner biotechnology startups, both within Korea and abroad, equipped with exclusive technologies, has allowed GC Biopharma to strengthen its position in the global biopharmaceutical field.
GC Biopharma’s R&D
RED DivisionHandles early-stage R&D to introduce new products into the pipeline.
MSAT DivisionHandles later-stage R&D and improves products.
Medicine DivisionConducts clinical trials on products before launching.
Development DivisionUndertakes development projects and handles Regulatory Affairs, Business Development.
Business Development Divisionbusiness development work to license in and out novel drug candidates.
Partnership with leading corporations worldwide
Biotechnology startup network
at home and abroad
Collaboration with academia
Collaboration with research organizations in and outside Korea